• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TSRO:US

28.2600 USD 1.5600 5.23%

As of 20:10:00 ET on 07/25/2014.

Snapshot for TESARO Inc (TSRO)

Open: 29.5000 Day's Range: 27.4600 - 29.5000 Volume: 367,484
Previous Close: 29.8200 52wk Range: 22.1501 - 47.8900 1-Yr Rtn: -17.85%

Stock Chart for TSRO

No chart data available.
  • TSRO:US 28.3000
  • 1D
  • 1M
  • 1Y
29.8200
Interactive TSRO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TSRO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.6888
Est. EPS (USD) (12/2014) -4.5070
Est. PEG Ratio -
Market Cap (M USD) 1,018.58
Shares Outstanding (M) 36.04
30 Day Average Volume 336,992
Price/Book (mrq) 6.7470
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TSRO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TSRO

Tesaro, Inc. develops and commercializes cancer therapeutics and supportive care products. The Company offers receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Tesaro identifies oncology therapeutics in the United States.

David M Mott "Dave"ChairmanLeon O Moulder Jr "Lonnie"CEO/Co-Founder
Mary Lynne HedleyPres/COO/Chief Scientific OfcrTimothy Pearson "Tim"Exec VP/CFO
More Company Profile & Key Executives for TSRO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil